Hi Sidney,
We discussed COG in our Q&A report last week and our view hasn’t changed, our summary is below:
COG is a $185mn financial services business which on the surface looks cheap trading on ~8x while yielding around 9% but the stocks halved since its 2022 high more than offsetting its dividend payouts. Insiders have been buying the stock above this week’s ~95c level with tranches going through between $1 and $1.40.
- Directors buying is a positive sign, but it’s not a stock we’d be buying given its current trend – we would call it neutral at best.
Loosely termed “Junior” gold miner EMR has a market cap. of $2.6bn having been a major market and sector outperformer over the last 2-years, it only entered the ASX200 in 2023. Its Cambodian gold operation makes it one of the world’s highest-margin producers with an average cost of production ~$US829, or $A1200, though, it’s all in sustaining costs (AISC), which also includes company operating expenses, sustaining capital expenditures, and exploration expenses, is more like $1400.
- We like EMR medium term but short-term a pullback wouldn’t surprise.